Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
03/09/1993 | US5192661 Multicomponent kit containing an antibody to a synthetic antigen of sialic acid |
03/09/1993 | CA1314254C Enzymatic membrane method for the synthesis and separation of peptides |
03/04/1993 | WO1993004089A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
03/04/1993 | WO1993004085A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
03/04/1993 | WO1993004079A1 Method for generating and screening useful peptides |
03/04/1993 | DE4129041A1 Recovery of valuable substances from body excretions and blood - by reducing the volume of the excretions, sepg. the valuable substance from the matrix, e.g. by filtration and e.g. chromatographing the retentate |
03/04/1993 | CA2116359A1 Anti-hiv proteins gap 31, dap 30, and dap 32, dna coding therefor and therapeutic uses thereof |
03/04/1993 | CA2116013A1 Method for generating and screening useful peptides |
03/04/1993 | CA2115925A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
03/03/1993 | EP0530167A1 New isosteric peptides |
03/03/1993 | EP0529604A1 Method of analysing a protein or a peptide |
03/03/1993 | EP0529573A1 Solid-phase synthesizer |
03/03/1993 | EP0529568A1 Novel orally-active elastase inhibitors |
03/03/1993 | EP0529504A2 Apparatus for the simultaneous synthesy of different peptides |
03/03/1993 | EP0529487A2 PACAP derivatives having c-AMP producing activity |
03/03/1993 | EP0529469A2 Substituted 2,3-diamino acids, process for their preparation and their use as intermediates for peptidic agents |
03/03/1993 | EP0529300A1 Novel recombinant human-IFN-beta, process for the preparation thereof and pharmaceutical compositions comprising the same |
03/03/1993 | EP0528864A1 Oxidation stable detergent enzymes |
03/03/1993 | EP0528841A1 A method for the preparation of pyridoxylated hemoglobin |
03/03/1993 | EP0528820A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase. |
03/02/1993 | US5191068 Removal of cells from an aqueous suspension |
03/02/1993 | US5191066 Site-specific conjugation of immunoglobulins and detectable labels |
03/02/1993 | US5191065 Process for the preparation of tripeptides |
03/02/1993 | US5191063 Production of biologically active polypeptides by treatment with an exogenous peptide sequence |
03/02/1993 | US5191015 Polymers and polymer-peptide conjugates |
03/02/1993 | US5190921 Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments |
03/02/1993 | US5190875 Peptide amidase and the use thereof |
03/02/1993 | CA1314011C Method for the purification of proteins |
03/02/1993 | CA1314010C Method to export gene products to the growth medium of gram negative bacteria |
03/01/1993 | CA2077186A1 Microemulsions |
03/01/1993 | CA2077002A1 Substituted 2,3-diamino acids, processes for their preparation and their use as intermediates for peptide active substances |
02/25/1993 | DE4127353A1 Controlled peptide synthesis - using alpha aminoacid ester(s) with transition metal complexes, useful as single pot reaction |
02/24/1993 | EP0528583A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
02/24/1993 | EP0528527A2 Conjugates |
02/24/1993 | EP0527954A1 Molecular recognition units |
02/24/1993 | EP0527778A1 Improved process of purifying recombinant proteins and compounds useful in such process. |
02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
02/24/1993 | EP0527763A1 Method to purify basic fibroblast growth factor |
02/24/1993 | EP0527761A1 Phosphonopeptides with collagenase inhibiting activity |
02/24/1993 | EP0527752A1 Expression of heterologous protein in yeast |
02/23/1993 | US5189148 Fibroblast growth factor; mixture with water insoluble hydroxypropyl cellulose |
02/23/1993 | US5189019 Antistasin derived anticoagulant protein |
02/23/1993 | US5188969 Monoclonal antibody to human lymphotoxin and use thereof |
02/23/1993 | US5188733 Apparatus and process for effecting sequential peptide syntheses |
02/23/1993 | US5188148 Conduit plate for fluid delivery system |
02/23/1993 | CA1313831C Method of generating desired aminoterminal residues in proteins and methods of regulating metabolic stability of proteins |
02/18/1993 | WO1993003134A1 Process for isolating and purifying recombinant interleukin-7 |
02/18/1993 | WO1993003062A1 Method of preferential labelling of a phycobiliprotein with a second dye to enable multiple color assay |
02/18/1993 | WO1993003060A1 Amide derivatives of antibiotic a 40926 |
02/18/1993 | WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
02/18/1993 | WO1993003058A2 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
02/18/1993 | WO1993003056A1 Lanthionine bridged peptides |
02/18/1993 | WO1993002992A1 Synthesis of chain chemical compounds |
02/18/1993 | WO1993002708A1 Novel reagent for tumour imaging and therapy |
02/18/1993 | DE4127256A1 Chromatographic isolation of proteins from e.g. blood esp. cytochrome C sepn. - by contacting with buffered macroporous cellulose@ beads, rinsing away impurities and eluting adsorbed proteins with different buffer |
02/18/1993 | CA2115246A1 Lanthionine bridged peptides |
02/18/1993 | CA2112566A1 Non-desensitizing analogs of gnrh and other biologically active ligands |
02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
02/17/1993 | EP0527149A1 Methods and apparatus allowing sequential chemical reactions. |
02/16/1993 | US5187270 Solid phase synthesis of peptides using the reaction product of an N-protected amino acid and a 2,4-dichlorophenyl (4-halo methylphenoxy)acetate; efficiency; purity; kinetics |
02/16/1993 | US5187156 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
02/16/1993 | US5187077 Leukaemia inhibitory factor |
02/16/1993 | US5187075 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
02/16/1993 | US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples |
02/16/1993 | US5186898 Single coupling |
02/16/1993 | US5186824 Rotating processor; sequential separation by fluid density |
02/16/1993 | CA2049275A1 Purification of sf hemoglobin |
02/10/1993 | EP0527069A1 Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them |
02/10/1993 | EP0527063A1 Production of protein of interest in the milk of transgenic mammal |
02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
02/10/1993 | EP0526854A2 Method for recovery of alpha-L-aspartyl-L-phenylalanine methyl ester, L-phenylalanine and l-aspartic acid |
02/09/1993 | WO1993002697A1 Production of peptide amides |
02/09/1993 | US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
02/09/1993 | US5185319 Administering a mixture of insulin and a 30hydroxypyrid-4-one |
02/09/1993 | US5185266 Cleaving an alkylated thiohydantoin adduct from a peptide under anhydrous, acidic conditions and analyzing the side chain of the amino acid |
02/09/1993 | CA2115159A1 Production of peptide amides |
02/09/1993 | CA2074700A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
02/04/1993 | WO1993002099A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
02/04/1993 | WO1993002098A1 Isolation of charged particles from fluids |
02/04/1993 | WO1993002097A1 Protein v: a novel igg binding factor |
02/04/1993 | WO1993001828A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
02/04/1993 | CA2113993A1 Protein v: a novel igg binding factor |
02/04/1993 | CA2113358A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
02/04/1993 | CA2113156A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
02/03/1993 | EP0526397A1 Immunological detection method |
02/03/1993 | EP0525992A2 Cluster conjugates of drugs with antibodies |
02/03/1993 | EP0525889A1 Process for phosphate ester compounds of certain cyclohexapeptides |
02/03/1993 | EP0525838A2 Growth hormone releasing factor analogs |
02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
02/03/1993 | EP0525502A1 Method for the preparation of virus-inactivated immunoglobuline solutions |
02/03/1993 | EP0525499A1 Amide derivatives of antibiotic A 40926 |
02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
02/02/1993 | US5183809 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
02/02/1993 | US5183660 Drugs having decreased antigenicity, delayed biological clearance and exhibit physiological activity over a long period |
02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
01/31/1993 | CA2074759A1 Process for phosphate ester compounds of certain cyclohexapeptides |
01/28/1993 | DE4124286A1 Verfahren zur stabilisierung von proteinen bei optischen tests A process for the stabilization of proteins in optical tests |
01/27/1993 | EP0524800A1 Adhesive formulations for binding proteins |
01/27/1993 | EP0524681A1 Process for the purification of serum albumin |